1<\/p>\n Patients have been advised to continue to take the medication as prescribed by their healthcare professionalsCredit: Getty<\/p>\n In its alert, UK medicines regulator, the MHRA said: “CD Pharma Ltd [the inhaler’s manufacturer] have notified the MHRA of an error on the outer carton of the product for the batches listed in this notification.<\/p>\n “While the total active content statement is correct, the delivered dose content statement is incorrect.”<\/p>\n The other product details on the inhaler carton, however, including the name, strength and pharmaceutical form of the medicine<\/a>, are correct. <\/p>\n And the quality of the medicine has not been impacted by the labelling defect. <\/p>\n Patients have been advised to continue to take the medication as prescribed by their healthcare professionals. <\/p>\n Meanwhile, healthcare professionals have been advised to stop supplying the above batch immediately. <\/p>\n The recall urged: “Quarantine all stock and return it to your supplier using your supplier’s approved process.”<\/p>\n The MHRA said: “This is a wholesale and pharmacy level recall that will be actioned by a healthcare professional.<\/p>\n “There is no quality issue with the product and patients can continue to take their medicine as prescribed.”<\/p>\n The labelling mistake means patients may have thought they were only receiving half the necessary dose of the medication. <\/p>\n Early Warning Signs of an Asthma Attack<\/p>\n As part of the recall, patients who do experience adverse reactions or have any questions about the medication are advised to seek medical attention. <\/p>\n Any suspected adverse reactions should also be reported via the MHRA Yellow Card Scheme<\/a>. <\/p>\n Asthma is a common condition. In the UK, 7.2 million people have asthma. This is about eight in every 100 people, according to Asthma + Lung UK<\/a>. <\/p>\n Medicine details<\/p>\n Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation, suspension<\/p>\n PL: 20492\/0724<\/p>\n Active Ingredient: fluticasone propionate\/formoterol fumarate<\/p>\n SNOMED code: n\/a<\/p>\n GTIN: 05060011835409<\/p>\n Affected lot batch numbers:<\/strong><\/p>\n 270185-24062FA-30424 – expiry date 30th June 2026 – pack size 120 Actuations – first distributed 30 Jun 2025<\/p>\n 270186-24065FA-30443 – expiry date 30 Jun 2026 – pack size 120 Actuations – first distributed 04 Jul 2025<\/p>\n 270774-24082FB-30444 – expiry date 31 Jul 2026 – pack size 120 Actuations – first distributed 04 Jul 2025<\/p>\n 269881-24064FA-30425 – expiry date 30 Jun 2026 – pack size 120 Actuations – first distributed 04 Jul 2025<\/p>\n \u00a0It affects the airways that carry air in and out of your lungs, causing them to become inflamed. <\/p>\n This makes the airways narrower so less air gets into and out of the lungs.<\/p>\n Symptoms, like wheezing, breathlessness, a cough or a tight chest, can be\u00a0triggered\u00a0by things like exercise<\/a>, allergens or changes in weather<\/a>.<\/p>\n At the moment there is no cure for asthma, but most people with asthma can control their symptoms well with\u00a0asthma inhalers. <\/p>\n![\"Woman](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/07\/young-woman-using-asthma-inhaler-1012025883.jpg\")
<\/a><\/p>\n